Differences in Sitting Versus Standing on Metabolic and Cardiovascular Measurements

January 29, 2025 updated by: Peter A. Hosick, Montclair State University
This investigations examined the effect that posture has on metabolic and cardiovascular measurements. Further, it will explore the potential for body weight status or physical activity to influence these relationships. All subjects will complete a seated condition and a standing condition in a counterbalanced manner.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Detailed Description

The purpose of the present study was to evaluate both metabolic and cardiovascular responses to acute bouts of computer work while sitting and standing. Cardiovascular measurements were made using continuous non-invasive blood pressure monitoring and metabolic measurements were made using indirect calorimetry. Subjects will be grouped and analyzed based upon the weight status of the subject. All subjects will complete a seated condition and a standing condition in a counterbalanced manner. Investigators hypothesize that metabolic and cardiovascular responses will be elevated in the standing condition compared to sitting.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Montclair, New Jersey, United States, 07043
        • Montclair State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Healthy subjects between the ages of 18 and 50 years.

Description

Inclusion Criteria:

  • healthy adult

Exclusion Criteria:

  • Have a history of cancer, cardiac issues, hypertension, pulmonary disease, stroke, neurological or muscular dystrophy, uncontrolled diabetes, or any life threatening chronic conditions.
  • Are currently being treated for infectious mononucleosis, hepatitis, pneumonia, or other infectious diseases.
  • Are unable or unwilling to stand in one position continuously for 15-20 minutes at a time.
  • Use nicotine products, or non-contraceptive hormonal therapy (birth control is okay).
  • Are pregnant or trying to become pregnant.
  • Are not between 18 and 50 years of age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Normal Weight
Group is determined based upon subjects weight status. Subjects will preform computer work in the seated and standing position in a counterbalanced manner while metabolic and cardiovascular measurements are made.
Subjects will be asked to both sit and stand during a single trial.
Overweight/Obese
Group is determined based upon subjects weight status. Subjects will preform computer work in the seated and standing position in a counterbalanced manner while metabolic and cardiovascular measurements are made.
Subjects will be asked to both sit and stand during a single trial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure heart rate based upon beat-by-beat finger pressure.
Approximately 15 minutes in each condition (sitting and standing)
Systolic Blood Pressure (SBP)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure SBP based upon beat-by-beat finger pressure.
Approximately 15 minutes in each condition (sitting and standing)
Diastolic Blood Pressure (DBP)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure DBP based upon beat-by-beat finger pressure.
Approximately 15 minutes in each condition (sitting and standing)
Oxygen Consumption
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Oxygen consumption will be measured using indirect calorimetry.
Approximately 15 minutes in each condition (sitting and standing)
Carbon Dioxide Production
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Carbon Dioxide will be measured using indirect calorimetry.
Approximately 15 minutes in each condition (sitting and standing)
Ventilation
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Ventilation will be measured using indirect calorimetry.
Approximately 15 minutes in each condition (sitting and standing)
Respiratory Exchange Ration (RER)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
RER will be calculated using oxygen and carbon dioxide value measure from indirect calorimetry.
Approximately 15 minutes in each condition (sitting and standing)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: 1 minute
Standard stadiometer will be used to measure height in meters.
1 minute
Weight
Time Frame: 1 minute
Standard scale will be used to measure weight in kilograms.
1 minute
Body Mass Index (BMI)
Time Frame: 1 minute
Height in meters and weight in kilograms will be used to calculate BMI using the formula BMI = kg/m^2.
1 minute
Body Composition
Time Frame: Approximately 15 minutes
Body composition will be measured using air displacement plethysmography.
Approximately 15 minutes
Total Peripheral Resistance (TPR)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be uses to estimate TPR based upon beat-by-beat finger pressure.
Approximately 15 minutes in each condition (sitting and standing)
Stroke Volume
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to estimate TPR based upon beat-by-beat finger pressure.
Approximately 15 minutes in each condition (sitting and standing)
Cardiac Output (Q)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to estimate Q based upon beat-by-beat finger pressure.
Approximately 15 minutes in each condition (sitting and standing)
Muscle Oxygen Saturation
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
Using Near-inferred spectroscopy muscle oxygen consumption will be monitored.
Approximately 15 minutes in each condition (sitting and standing)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2018

Primary Completion (Estimated)

May 15, 2028

Study Completion (Estimated)

May 15, 2028

Study Registration Dates

First Submitted

April 22, 2019

First Submitted That Met QC Criteria

April 24, 2019

First Posted (Actual)

April 25, 2019

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 29, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 17-18-861

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on sit/stand

Subscribe